![]() |
市場調査レポート
商品コード
1601597
閉鎖式薬物移注デバイス (CSTD) の世界市場:タイプ・コンポーネント・閉鎖メカニズム・技術・地域別の予測 (~2032年)Global Closed System Drug Transfer Device Market Research Report Information By type, By Component, By Closing Mechanism, By Technology By Region- Forecast to 2032 |
||||||
|
閉鎖式薬物移注デバイス (CSTD) の世界市場:タイプ・コンポーネント・閉鎖メカニズム・技術・地域別の予測 (~2032年) |
出版日: 2024年11月15日
発行: Market Research Future
ページ情報: 英文 146 Pages
納期: 即納可能
![]() |
閉鎖式薬物移注デバイス (CSTD) の市場規模は、2023年の10億7,000万米ドル、2024年の12億米ドルから、予測期間中は10.17%のCAGRで推移し、2032年には28億7,000万米ドルの規模に成長すると予測されています。ヘルスケア業界の厳しい規制と世界の癌の発症頻度の増加が市場の発展の原動力となっています。
世界の癌の罹患率の増加が、世界の閉鎖式薬物移注デバイス (CSTD) 市場を牽引しています。癌治療では通常、危険な薬剤を使用する必要があり、それを扱う医療従事者の健康を損なう恐れがあるためです。密閉された漏れ防止機構を使用することで、このような危険な薬剤が周囲に放出されるのを防ぐことができます。
地理的洞察
北米地域は2023年に最大の市場シェアを示し、予測期間中は9.10%のCAGRで推移し、2032年には99億2,000万米ドルに達すると予測されています。
北米は38.14%で最大のシェアとなる見込みです。強力な研究開発インフラと癌患者の増加が、この大きなシェアの主な要因です。米国では2020年に160万3,844人の新規癌患者と60万2,347人の癌死亡者が報告されています。
アジア太平洋地域は大幅な成長が見込まれており、予測期間中はもっとも急成長すると予測されています。これは、多数の地域企業および小規模参入企業がシェア獲得に取り組んでいることに起因しています。
当レポートでは、世界の閉鎖式薬物移注デバイス (CSTD) の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global Closed System Drug Transfer Device Market Research Report Information By type (Membrane to Membrane and Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, and Air Filtration Devices) By Region- Forecast to 2032
Market Profile
The Closed System Drug Transfer Device Market is expected to have value USD 1.07 billion in 2023. From USD 1.20 billion in 2024 to USD 2.87 billion by 2032 the sector is expected to have a compound annual growth rate (CAGR) of 10.17%. The rigorous regulations of the healthcare industry and the worldwide increasing frequency of cancer are driving development in the market.
Importantly, the growing worldwide cancer prevalence is driving the global closed-system drug transfer device (CSTD) market. This is so because cancer therapy usually requires the use of dangerous drugs that could compromise the health of medical professionals handling them. By use of a closed and leak-proof mechanism, the device is meant to stop the release of these dangerous drugs into the surroundings. Furthermore driving the rising global cancer burden include environmental causes, aging population, better diagnosis tools, and lifestyle choices promoting market expansion.
Segregation of the market
Based on type, the worldwide closed-system drug transfer device market is divided into superfluous systems and membrane-to- membrane systems.
Four categories have been established out of the market: vial access devices, hypodermic safety devices, bag/line access devices, and accessories. The component grounds this division.
Four markets have been developed out of the market: push-to--turn systems, color-to--color alignment systems, leur lock systems, and click-to-lock systems. The closure mechanism forms basis for this classification.
Based on technology, the Closed System Drug Transfer Device Market now consists of air filtration devices, diaphragm-based devices, and compartmentalized devices.
The Market has been segmented into hospitals & clinics, specialty centers, and others based on the end consumer.
Geographic Insights
The Closed System Drug Transfer Device Market has been segmented into the Rest of the World, Asia-Pacific, Europe, and North America based on region. It is anticipated that North America will account for the largest market share in 2023 and reach USD 9.92 billion by 2032, with a compound annual growth rate (CAGR) of 9.10% during the forecast period.
The global CSTD market is expected to be dominated by North America, which holds the largest market share of 38.14%. The strong research and development infrastructure and the increasing prevalence of cancer cases are the primary factors contributing to this substantial market share. For example, in 2020, the United States reported 1,603,844 new cancer cases and 602,347 cancer fatalities.
Asia-Pacific is anticipated to experience substantial growth and is anticipated to be the fastest-growing region during the forecast period. This is attributed to the growing number of new vendors involved in the drug-device system, as numerous regional and small market participants are attempting to leverage their market share.
The Closed System Drug Transfer Device Market is distinguished by the presence of numerous global, regional, and local vendors. The market is intensely competitive, with all participants striving to acquire the largest possible market share. Market growth is significantly influenced by intense competition, frequent changes in government policies, and regulations.
Becton, Dickson, and Company, Inc., Baxter International Inc., ICU Medical, Inc., JMS Co.Ltd, B. Braun SE, Simplivia (Israel), Becton, Cormed (US), Yukon Medical (US), Caragen Ltd. (Ireland), and Equashield are among the major players in the Closed System Drug Transfer Device Market.